Time to treatment and complexity of Mohs micrographic surgery.

Arch Dermatol Res

Department of Dermatology, Johns Hopkins University School of Medicine, Johns Hopkins Outpatient Center, Room 8072, 601 N. Caroline St, Baltimore, MD, 21287, USA.

Published: August 2023

The impact of time to treatment (TTT) on the surgical management of keratinocyte carcinoma, specifically the complexity of Mohs micrographic surgery (MMS), is incompletely understood. We performed a retrospective chart review of patients undergoing MMS for keratinocyte carcinoma between July 1, 2019 and February 28, 2021 to examine associations between TTT and surgical characteristics. The median TTT for the 1571 patients treated with MMS during the study period was 42 days (interquartile range 28-61 days). In adjusted analyses, increasing TTT was not associated with increasing utilization of flap or graft repairs. Although a 42-day increase in TTT was associated with a 17.6 mm increase in the post-operative surgical defect size after MMS, TTT was not associated with linear repair length or flap/graft repair area. In conclusion, TTT was not independently associated with the type of repair or repair length after MMS, suggesting that the complexity of Mohs reconstruction is not influenced by TTT within the time range studied in this cohort.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801139PMC
http://dx.doi.org/10.1007/s00403-022-02519-9DOI Listing

Publication Analysis

Top Keywords

complexity mohs
12
ttt associated
12
time treatment
8
mohs micrographic
8
micrographic surgery
8
ttt
8
ttt surgical
8
keratinocyte carcinoma
8
repair length
8
mms
5

Similar Publications

Surface mold brachytherapy for head and neck non-melanoma skin cancer - local control rates and survival: A retrospective analysis.

J Contemp Brachytherapy

October 2024

Department of Radiation Oncology, Cancer Institute, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Purpose: Non-melanoma skin cancer (NMSC) is the most prevalent cancer worldwide, particularly affecting head and neck region. Surgical excision, especially Moh's microsurgery, is the gold standard for treatment. However, certain patients' factors, such as age, comorbidities, and tumor location, require alternative therapies.

View Article and Find Full Text PDF

Lip Reconstruction.

Semin Plast Surg

November 2024

Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.

Lip reconstruction is challenging for plastic surgeons due to the unique functionality and aesthetic complexity of the lips within the lower third of the face. The etiology of lip defects varies from congenital to acquired causes of origin. The most common acquired cause of lip defects is resection of malignancy.

View Article and Find Full Text PDF

Background: In dermatology, the majority of opioid prescriptions occur in dermatologic surgery. Even short courses of opioids are linked to substance abuse. Reported rates of opioid prescription in dermatologic surgery are variable, with no consensus on when they should be prescribed.

View Article and Find Full Text PDF

Dr. Frederic E. Mohs significantly advanced the treatment of skin cancer with the development of Mohs micrographic surgery (MMS).

View Article and Find Full Text PDF
Article Synopsis
  • Managing large skin defects after Mohs surgery can be tough, especially in areas with low skin elasticity, requiring complex reconstruction techniques to ensure good results.
  • A 78-year-old man with basal cell carcinoma underwent Mohs surgery, which left a 1.5 x 1.5 cm defect on his ear.
  • The authors successfully used a bilateral pedicle advancement flap for closure, a rare method in dermatologic surgery, leading to excellent outcomes and no complications after 10 months.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!